Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0%	78.35	$
AZN	0.17%	90.18	$
RELX	-0.55%	40.32	$
RYCEF	-0.34%	14.62	$
CMSC	-0.21%	23.43	$
SCS	-0.56%	16.14	$
BTI	-1.81%	57.01	$
VOD	-1.31%	12.47	$
NGG	-0.66%	75.41	$
GSK	-0.33%	48.41	$
BCC	-1.66%	73.05	$
CMSD	-0.3%	23.25	$
RIO	-0.92%	73.06	$
JRI	0.29%	13.79	$
BCE	1.4%	23.55	$
BP	-3.91%	35.83	$

Featured

Witness in South Africa justice-system crimes probe shot dead

A witness in a high-profile inquiry into crime and corruption in South Africa's justice system was gunned down late on Friday, just weeks after implicating a municipal police chief, investigators said.

10 university students die in Peru restaurant fire

Ten university students died and three were injured in a restaurant fire in southeastern Peru as they gathered for a birthday celebration, police said Friday.

Last news

Local hero: 'DC sandwich guy' found not guilty of assaulting officer with sub

A US man charged with using a sandwich to assault a law enforcement officer was acquitted Thursday after a jury decided that charges brought by President Donald Trump's prosecutors were baloney.

UK grandmother on Indonesia death row flies home

Two British drug convicts including a grandmother on death row flew home early on Friday, as part of a deal to return them on humanitarian grounds.

Dr. Todd H. Lanman Presents First-Ever Public Results of the Synergy Disc(R) 1-Level IDE Clinical Trial at DOCS Health's 7th Annual Spine Arthroplasty Summit

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months compared with fusion surgery

Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment

VANCOUVER, BC / ACCESS Newswire / November 7, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that its subsidiary, Inka Health Corp. ("InkaHealth"), has published a technical primer[1] on the transportability of real-world evidence (RWE) titled Transportability of Non-Local Real-World Evidence and Its Relevance to Health Technology Assessment in the Journal of Clinical Evaluative Research (JCER). This primer, co-authored with experts at AstraZeneca Canada, addresses a critical challenge in global healthcare decision-making by demonstrating how advanced statistical transportability methods can adapt medical evidence from one country for use in another. These methods have the potential to accelerate regulatory approvals and improve patient access to innovative therapies, particularly in rare diseases where local data are often limited.

Havertys Furniture Announces Fourth Quarter Cash Dividend

ATLANTA, GA / ACCESS Newswire / November 7, 2025 / HAVERTY FURNITURE COMPANIES, INC. (NYSE:HVT, HVT.A) announced today that its Board of Directors declared a $0.01 increase in the quarterly dividend, from $0.32 per share to $0.33 per share on the company's common stock. The quarterly dividend for the company's Class A common stock is also being increased from $0.30 to $0.31 per share. The dividend is payable on December 11, 2025, to stockholders of record at the close of business on November 25, 2025. Havertys Furniture has paid a cash dividend in each year since 1935.

Razor Sharp PR Unveils Industry's First Framework for Winning AI Citations

New white paper bridges gap between AI research labs and modern communications strategies

Razor Sharp PR Recognized as National Finalist for "Thought Leadership Communications" Award

The firm's campaign on behalf of ITR Economics has earned a place at the 2025 Ragan PR Daily Awards ceremony in NYC; winners to be announced December 2

Releaf Dispensary Ltd Announces UK Cannabis Survey: 97% See Quality of Life Gains

Largest UK Active Medical Cannabis Patient Survey shows 97% improvement in quality of lifeThe Findings from Releaf, shows major improvements in pain, sleep and anxiety, landmark UK study finds.

Dolphin to Host Third Quarter 2025 Earnings Call on November 12 at 4:30 PM ET

MIAMI BEACH, FLORIDA / ACCESS Newswire / November 7, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment, marketing, and communications company, today announced it will host a conference call to discuss financial results for its third quarter ended September 30, 2025, on November 12, 2025, at 4:30pm ET.

Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / New to The Street, one of America's leading business television and multi-platform media brands, today announced a comprehensive media partnership with Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence company developing cancer medicines with multiple clinical-stage programs.

UniDoc to Exhibit at ANCI 2025 in Bologna, November 12-14

VANCOUVER, BC / ACCESS Newswire / November 7, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") will attend and exhibit at the 42nd Annual ANCI Assembly in Bologna, Italy, from November 12-14, 2025.

BGSF, Inc. Reports Third Quarter 2025 Financial Results and Announced a Stock Buyback Plan

PLANO, TX / ACCESS Newswire / November 7, 2025 / BGSF, Inc. (NYSE:BGSF), a leading provider of workforce solutions for the specialized Property Management industry, today reported financial results for the third fiscal quarter ended September 28, 2025 and announced a stock buyback plan.

Borussia Dortmund Reports Preliminary Figures for the First Quarter (Q1) of the 2025/2026 Financial Year

DORTMUND, GERMANY / ACCESS Newswire / November 7, 2025 / In the first quarter of the 2025/2026 financial year (1 July 2025 - 30 September 2025), Borussia Dortmund's consolidated earnings before taxes (EBT) rose by EUR 23.9 million to EUR 25.6 million (prior-year quarter: EUR 1.7 million). This is due primarily to a rise in net transfer income, which increased by EUR 33.6 million as against the prior-year quarter to EUR 52.9 million. Consolidated revenue remained level year-on-year, at EUR 107.0 million (prior-year quarter: EUR 107.3 million).

US Supreme Court backs Trump admin's passport gender policy

The US Supreme Court allowed the Trump administration on Thursday to require passport applicants to be identified on the document by their biological sex at birth rather than their gender identity.

'Grand Theft Auto VI' video game delayed again until Nov. 2026

The newest installment to the blockbuster "Grand Theft Auto" video game franchise has been delayed again, this time until November 2026, its creators announced Wednesday.

Rally outside Rockstar against GTA studio's 'union busting'

Dozens of people protested Thursday outside Rockstar Games' offices in Edinburgh, accusing the multi-billion dollar studio behind the smash "Grand Theft Auto" open-world carjacking franchise of "blatant union busting" by firing 31 people.

Mexico's Sheinbaum to boost reporting of sexual abuse after being groped

Mexican President Claudia Sheinbaum on Thursday unveiled proposals to boost reporting and prosecution of sexual abuse after herself being groped in the street in an attack that caused outrage.

Kirchner on trial in Argentina's 'biggest ever' corruption case

Argentine ex-president Cristina Kirchner, already serving a six-year fraud sentence under house arrest, went on trial Thursday in a new corruption case described as the biggest in her country's history.

UK grandmother leaves Indonesia death row to return home

Two British drug convicts including a grandmother on death row left a Bali jail on Thursday, as part of a deal to send them home on humanitarian grounds.

Police say 19 held after raid at Swedish start-up Stegra to be deported

Police said Thursday that 19 people they caught working illegally during a raid at the Swedish start-up Stegra's steel mill would be deported.

Argentine ex-president Kirchner goes on trial in new corruption case

Argentine ex-president Cristina Kirchner, who is serving a six-year fraud sentence under house arrest, goes on trial Thursday in a separate case for allegedly taking millions of dollars in bribes.

New Zealand ex-top cop admits to having material showing child abuse, bestiality

New Zealand's former deputy police commissioner admitted on Thursday to possessing child sexual exploitation and bestiality material, which he had stored on his work devices.

Australian kingpin obtains shorter sentence over drug charge

Australia's most famous gangster won a reduced jail sentence Thursday on one of his drug-related convictions, after it was revealed his lawyer was a police informant.

Philippine death toll tops 140 as typhoon heads towards Vietnam

Typhoon Kalmaegi killed at least 140 people and left another 127 missing after unleashing devastating flooding across the central Philippines, official figures showed Thursday, as the storm headed towards Vietnam.

Belgium probes drone sightings after flights halted overnight

Belgian authorities on Wednesday investigated drone sightings that halted air traffic overnight at several airports, as flights resumed after hundreds of passengers were left stranded.

Engine fell off US cargo plane before deadly crash: officials

The death toll from a cargo plane crash in the southern US state of Kentucky rose to 11 on Wednesday, with investigators saying the accident was caused by one of the engines catching fire and detaching during takeoff.

Menhaden Fisheries Coalition Applauds Louisiana Wildlife & Fisheries Commission for Balanced, Science-Based Buffer Zone Recommendations

BATON ROUGE, LA / ACCESS Newswire / November 6, 2025 / The Menhaden Fisheries Coalition applauds the Louisiana Wildlife and Fisheries Commission for voting today in favor of a balanced proposal to modify menhaden buffer zones along portions of the Louisiana coast. The vote reflects a careful, science-first approach: state officials studied the issue, listened to stakeholders, and brought forward a proposal that adds new protections and enlarges the total protected footprint, even as it makes targeted, common-sense adjustments where warranted. Paired with the fleet's standardized hose-end cage gear and ongoing collaboration with stakeholders, this is the right path to keep Louisiana's fisheries healthy and its coastal communities working.

President Trump's Decision on Medical Cannabis Will Define His Legacy: Science or Marijuana Policy Stagnation

After DOJ Concedes DEA's Courts Are Unconstitutional, MMJ BioPharma Cultivation's Fight for Patients Lands on President Trump's Desk

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 6, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its financial results for the three and nine months ended September 30, 2025.

NHI Announces Fourth Quarter 2025 Dividend

MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.92 per common share on January 30, 2026, to stockholders of record as of December 31, 2025.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Reports Net Revenues of $191.8 million for the Three Months Ended September 30, 2025GAAP net income of $17.4 million, or $0.37 per share, for the third quarterAdjusted non-GAAP net income of $44.7 million, or $0.93 per share, for the third quarterCompany to hold a conference call today at 2:00 p.m. Pacific Time

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was submitted in SeptemberRusfertide granted breakthrough designation for patients in Polycythemia Vera (PV) and the subject of four presentations including 52-week results of the VERIFY Phase 3 Study at ASH, the 67th Annual American Society of Hematology (ASH) meeting in DecemberFirst patient dosed in the Phase 1 trial of PN-881, a first-in-class oral IL-17 peptide antagonistIND-enabling studies progressing as planned with triple-GLP/GIP/GCG agonists PN-477sc and PN-477oOral hepcidin development candidate expected to be nominated by year endCash, cash equivalents and marketable securities of $678.8 million as of September 30, 2025, anticipated to provide cash runway through at least end of 2028

Arizona Tribune - Boulevard (English)